Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease

Area of Science:

• Immunogenetics
• Molecular Medicine
• Hematology

Background:

• Sickle cell disease (SCD) is a prevalent monogenic disorder with significant, yet incompletely understood, phenotypic variability.
• Inflammation is a key driver of SCD pathophysiology, suggesting a role for genetic variations in inflammatory pathway genes.
• Single nucleotide polymorphisms (SNPs) in immune-related genes may influence the manifestation and severity of SCD complications.

Purpose of the Study:

• To investigate the association between SNPs in inflammatory genes and the occurrence of six major SCD clinical complications.
• To identify genetic markers that may predict susceptibility to or protection against SCD complications.

Main Methods:

• A cohort of 500 SCD patients was analyzed for associations between 20 SNPs in Toll-like receptors (TLR), NK cell receptors (NKG), HLA, MICA, and CTLA-4 genes.
• The study assessed the frequency of specific genotypes and alleles in relation to complications such as stroke, acute chest syndrome (ACS), leg ulcers, cholelithiasis, osteonecrosis, and retinopathy.
• Logistic regression analysis was employed to determine the risk and protective effects of identified SNPs on SCD complications.

Main Results:

• Specific genotypes of TLR2 (rs4696480 TA, rs3804099 CC) and HLA-G (rs9380142 AA) were associated with fewer SCD complications.
• The HLA-G rs9380142 G allele increased the risk of cholelithiasis, while SNPs in the NKG2D loci (rs2246809, rs2617160, rs2617169) were linked to a lower frequency of retinopathy.
• These findings highlight specific genetic variations that modulate SCD clinical outcomes.

Conclusions:

• Genetic variations in inflammatory pathway genes, including TLR2, HLA-G, and NKG2D, significantly influence the susceptibility to and protection against sickle cell disease complications.
• The identified SNPs may serve as potential biomarkers for predicting SCD severity and guiding personalized patient management.
• Further research into these genetic associations can enhance understanding of SCD pathogenesis and inflammatory mechanisms.